According to the National Multiple Sclerosis Society, more than 2.3 million people are affected by MS worldwide. What is the clinical evidence for cannabis therapy in multiple sclerosis?
There is evidence that cannabis-based medicine can significantly reduce spasticity, pain, and cause a subjective improvement in sleep quality compared to placebo in clinical trials. Cannabis-based medicine can also result in an objective improvement in mobility and bladder dysfunction. The undesirable side effects observed are often mild and well tolerated.